STAT3 and breast cancer: Our results show that LLL-3 inhibits STAT3-specific DNA binding activity in U373 glioblastoma cells and MDA-MB-231 breast cancer cells (Figure 1B) as well as inhibits STAT3-dependent transcription activity in luciferase assays in MDA-MB-231 breast cancer cells (Figure 1B).